Cigna Slumps Despite Q1 Earnings Beat

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cigna Slumps Despite Q1 Earnings Beat

© Thinkstock

Cigna Corp. (NYSE: CI) reported its first-quarter financial results before the markets opened on Friday. The company posted $2.32 in earnings per share (EPS) on $9.92 billion in revenue. That compared to consensus estimates from Thomson Reuters of $2.15 in EPS on revenue of $10.00 billion. In the same period of last year, Cigna reported EPS of $1.96 and $9.39 billion in revenue.

In terms of guidance for the full year, Cigna expects to have EPS in the range of $8.95 to $9.35 and revenues growing in the mid-single digit percentage. The consensus estimates call for $9.18 in EPS on $40.08 billion in revenue.

On the books, cash and marketable investments totaled $2 billion at the end of the quarter, compared to $1.4 billion at the end of 2015.

The company reported its revenue streams for the first quarter as follows:

  • Premiums had revenues of $7.75 billion.
  • Fees had revenues of $1.13 billion.
  • Net Investment Income had revenues of $272 billion.
  • Mail Order Pharmacy revenues had $697 million.
  • Other revenues totaled $68 million.

[nativounit]
David M. Cordani, president and CEO of Cigna, commented:

Our strong first quarter results reflect the continued focused execution of Cigna’s global strategy. Cigna’s ability to deliver quality outcomes and affordability reflects the value Cigna delivers to our customers and clients while continuing to position for success in our combination with Anthem.

Shares of Cigna traded down more than 3% to $130.65 Friday morning, with a consensus analyst price target of $169.58 and a 52-week trading range of $123.54 to $170.68.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618